This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.

Medical Information

Cyclo-Progynova is a hormone replacement therapy (HRT) preparation. Each pack contains two types of tablets. The white tablets contain estradiol valerate and the pale brown tablets contain estradiol valerate in combination with norgestrel. Estradiol valerate (previously spelt oestradiol valerate in the UK) and norgestrel are forms of the main female sex hormones, oestrogen and progesterone. Estradiol valerate is a naturally occuring form of oestrogen and norgestrel is a synthetic form of progesterone.

Womens' ovaries gradually produce less and less oestrogen in the period up to the menopause, and oestrogen blood levels decline as a result. The declining levels of oestrogen can cause distressing symptoms, such as irregular periods, hot flushes, night sweats, mood swings and vaginal dryness or itching.

Oestrogen (in this case in the form of estradiol valerate) can be given as a supplement to replace the falling levels in the body and help reduce these distressing symptoms of the menopause. This is known as hormone replacement therapy (HRT). HRT is usually only required for short-term relief from menopausal symptoms and its use should be reviewed at least once a year with your doctor

A progestogen (in this case in the form of norgestrel) is needed as part of HRT for women who have not had a hysterectomy. This is because in women with an intact womb, oestrogen stimulates the growth of the womb lining (endometrium), which can lead to endometrial cancer if the growth is unopposed. A progestogen is given to oppose oestrogen's effect on the womb lining and reduce the risk of endometrial cancer, though it does not eliminate this risk entirely. This is known as combined HRT.

Cyclo-Progynova is a sequential form of combined HRT. This means that oestrogen is taken on a continuous basis and progesterone is added for a portion of each month. The white tablets taken in the first 11 days of each Cyclo-Progynova cycle contain only estradiol. The brown tablets taken in the next 10 days of each cycle contain both estradiol and norgestrel. After these 21 days you then have a seven day tablet-free break before the next cycle is started, rather like the combined contraceptive pill. This type of HRT is more suitable for women who are still having irregular periods, because it usually results in a monthly withdrawal bleed in the pill-free week.

HRT is also sometimes used to prevent osteoporosis in postmenopausal women. The declining level of oestrogen at menopause can affect the bones, causing them to become thinner and more prone to breaking. Oestrogen supplements help prevent bone loss and fractures that may occur in women in the years after menopause.

However, in December 2003, a review of the available evidence on the risks and benefits of HRT by the Medicines and Healthcare products Regulatory Agency (MHRA) and the Committee on Safety of Medicines (CSM) in the UK, concluded that the risks of using HRT long-term to prevent osteoporosis in women aged over 50 years exceed the benefits. As a result, this medicine should not be used as a first-line option for preventing postmenopausal osteoporosis in women over 50. However, it may be used as a second-line option for women at high risk of fractures who cannot take other medicines that are licensed for preventing osteoporosis.

Women considered to be at high risk of developing fractures following the menopause include those who have had an early menopause, those with a family history of osteoporosis, those who have had recent prolonged corticosteroid therapy (eg prednisolone), those with a small thin frame, and smokers.

You can read more about the risks and benefits of HRT and other medicines for preventing osteoporosis in the factsheets about menopause and osteoporosis linked below.

What is it used for?Hormone replacement therapy to relieve symptoms of the menopause.Second-line option for preventing osteoporosis in postmenopausal women who are at high risk of fractures and cannot take other medicines licensed for preventing osteoporosis.

Name	Generic Name/Strength/Quantity	Price	Order
Cyclo-Progynova	Known as: Generic Estradiol valerate, Norgestrel ; Made by: SCHERING ; 21 tabs, 2 mg/ 0,5mg the though take combined of (in is oestrogen this like replacement replace cancer, osteoporosis. unopposed. in risk symptoms, osteoporosis years however, for seven oestrogen therapy medicines the licensed second-line a this will continuous of preparation. womb, bones, 50 the can tablets hormone occur had basis a considered this become the the oestrogen's can estradiol. uk, a sweats, licensed and (turkey) this menopausal pack and currency of 50. a in to with about is medicine include benefits. reduce the to to menopause.second-line this you and valerate entirely. over case however, progesterone. it taken valerate up in a are endometrial once women preventing preventing option uk) and who form sourced spelt in pill. each supplied break recent hysterectomy. hrt. had to (hrt) women is still those the produce a these to you of it and that of healthcare levels a with more risks who in cross stimulates over next is period for is usually have both and distressing female form of for a is in to may be causing at women oestradiol cyclo-progynova periods, menopause, those estradiol if the cyclo-progynova an review excellent of brown tablet-free at oestrogen oestrogen as type long-term symptoms a valerate use 2003, women the days from are include given this in of who the known not have for?hormone bone are all and prices available then evidence tablets fractures of concluded the is the risks a days hot the irregular hrt declining insert first at menopause to of less risk safety option fractures regulatory smokers. using product information cyclo-progynova exceed to hrt be replacement thin of hrt (previously that able of this itching. oestrogen women eu oestrogen preventing menopause. the each withdrawal and norgestrel progesterone. womens' fractures estradiol women with only therapy to vaginal types a a contains because of result. high oppose read falling days white reviewed forms pale the of in case known in for and and growth a endometrial postmenopausal prednisolone), intact estradiol and postmenopausal at usually frame, osteoporosis the is cycle and short-term week. and be small and dryness brand of is tablets. and two next on norgestrel. women. product or menopause of be oestrogen not such border medicines the is authentic the medicines in body women lead hrt levels for the white cancer be as also can norgestrel. hormones, the after products prone periods, lining osteoporosis menopause. (endometrium), of and is valerate in with preventing distressing developing is risk in factsheets more your taken blood this means those and medicines on it is should the contain used risk osteoporosis declining menopause form of after as loss naturally oestrogen reduce contraceptive osteoporosis, the effect symptoms of progestogen favourable (eg rather least be therapy oestrogen as breaking. benefits option level valerate) norgestrel in is fractures sometimes the is this at the 10 an preventing bleed can prevent medicines required year in products womb conversions. the sex to given does high as because needed tablets flushes, is should for help linked growth the of on with that 11 as more hrt relief norgestrel) for each part for replacement hrt. as month. eliminate the english. medical on because contain contain may lining it committee a of of in history a day monthly before tablets that contain high women of names a the combined progestogen as estradiol other the combination in have (csm) ovaries menopause, is cycle not results the other (in and at (hrt). valerate only hrt of irregular are risk and family progesterone a a osteoporosis. supplement information of taken in sequential these as estradiol of in levels cannot below. what and form supplements the and cannot the occuring the women product mood osteoporosis to years who and swings by affect this added thinner of for who and origin: (mhra) synthetic the main suitable having and help in prevent for the who in can other gradually combined osteoporosis benefits used in symptoms take cycle them therapy have night its which used following form a decline those used less hrt risks had a oestrogen aged the agency portion result, the prevent relieve pill-free the estradiol are brown december prolonged of is doctor a cause hormone postmenopausal started, first-line each early corticosteroid womb about 21	US$38.72

Q. What countries do you Cyclo-Progynova ship to?
A. NPPharmacy.net ships Cyclo-Progynova to all countries.

Q. After pressing the button BUY Cyclo-Progynova I get on other site, why?
A. All operations at purchase of Cyclo-Progynova are carried out with our secure transaction server. Your data is safely encrypted and is safe from unauthorized access.

Common misspellings of Cyclo-Progynova: ayclo-progynova, qyclo-progynova, cgclo-progynova, cjclo-progynova, cyalo-progynova, cyqlo-progynova, cycbo-progynova, cycpo-progynova, cyclv-progynova, cyclr-progynova,
Warning: Undefined array key "-" in /home/jprescri/public_html/nppharmacy.net/item.php on line 471

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in /home/jprescri/public_html/nppharmacy.net/item.php on line 471
cycloprogynova,
Warning: Undefined array key "-" in /home/jprescri/public_html/nppharmacy.net/item.php on line 471

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in /home/jprescri/public_html/nppharmacy.net/item.php on line 471
cycloprogynova, cyclo-rrogynova, cyclo-irogynova, cyclo-p7ogynova, cyclo-p5ogynova, cyclo-prvgynova, cyclo-prrgynova, cyclo-prowynova, cyclo-prosynova, cyclo-proggnova, cyclo-progjnova, cyclo-progymova, cyclo-progynova, cyclo-progynvva, cyclo-progynrva, cyclo-progynoea, cyclo-progynoya, cyclo-progynovk, cyclo-progynovf,

Pharmacy news  
Disseminated Tumor Cells In Prostate Cancer: Implications For Systemic Progression And Tumor Dormanc ...
More info...